Four Italian experiences on vaccination policies: results and lessons.
Age Factors
Child, Preschool
Diphtheria
/ prevention & control
Hepatitis B
/ prevention & control
Humans
Immunization Programs
/ legislation & jurisprudence
Infant
Italy
Leadership
Mandatory Programs
/ legislation & jurisprudence
Measles-Mumps-Rubella Vaccine
/ administration & dosage
Poliomyelitis
/ prevention & control
Social Media
Tetanus
/ prevention & control
Vaccination Refusal
Vaccines
/ administration & dosage
Immunization policies
Italy
Vaccines
Journal
Annali di igiene : medicina preventiva e di comunita
ISSN: 1120-9135
Titre abrégé: Ann Ig
Pays: Italy
ID NLM: 9002865
Informations de publication
Date de publication:
Historique:
entrez:
18
4
2019
pubmed:
18
4
2019
medline:
15
5
2020
Statut:
ppublish
Résumé
In 2018 the Council of Europe adopted a Recommendation on strengthened cooperation against vaccine preventable diseases. Among EU Member States, Italy has a long-lasting tradition of immunization policies implemented in the context of the National Health Service over the last forty years. We identify, report and critically appraise four immunization strategies implemented in Italy in recent years and quantitatively assess their impact on coverage rates and other selected indicators. First: the regional law that suspended mandatory vaccination in the Veneto Region in 2007 to stimulate a proactive approach to vaccine uptake was not successful. Second: a strengthened political commitment started in 2014 brought to the release of an innovative and updated National Immunization Prevention Plan and to encouraging increase in vaccine confidence and vaccination uptake. Third: the success of social media influencers is exemplified by the case of Roberto Burioni, professor of microbiology, who in 2015 started a personal social media campaign to contrast anti-vaccinists. Fourth: The new 2017 Italian law extending mandatory vaccinations has successfully impacted on vaccine coverage which increased by more than 1% and 4% for polio and MMR vaccines, respectively, in the first six months since its entering into force, and has continued to raise in 2018. Our data and real-life case studies offer to the broader European public health community a solid basis for discussion and ground to evaluate similar polices implemented in different European settings, with the common goal to share best practices and promote the culture of immunization.
Identifiants
pubmed: 30994162
doi: 10.7416/ai.2019.2275
doi:
Substances chimiques
Measles-Mumps-Rubella Vaccine
0
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM